Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY40.98 CNY
Change Today +3.02 / 7.96%
Volume 22.5M
600161 On Other Exchanges
Symbol
Exchange
Shanghai
As of 3:05 AM 04/21/15 All times are local (Market data is delayed by at least 15 minutes).

beijing tiantan biological-a (600161) Snapshot

Open
CNY37.88
Previous Close
CNY37.96
Day High
CNY41.76
Day Low
CNY37.80
52 Week High
04/14/15 - CNY44.00
52 Week Low
05/9/14 - CNY16.59
Market Cap
21.1B
Average Volume 10 Days
8.8M
EPS TTM
CNY0.26
Shares Outstanding
515.5M
EX-Date
07/19/12
P/E TM
160.6x
Dividend
--
Dividend Yield
--
Current Stock Chart for BEIJING TIANTAN BIOLOGICAL-A (600161)

Related News

No related news articles were found.

beijing tiantan biological-a (600161) Related Businessweek News

No Related Businessweek News Found

beijing tiantan biological-a (600161) Details

Beijing Tiantan Biological Products Co., Ltd. engages in the research, production, and sale of bacterial and viral vaccines, blood products, diagnostic supplies, and other biological products in China. Its products include hepatitis B vaccine, polio vaccine, MMR vaccine, Japanese encephalitis vaccine, influenza vaccine, varicella vaccine, human serum albumin, intravenous human immunoglobulin, and other species. The company is based in Beijing, China.

beijing tiantan biological-a (600161) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing tiantan biological-a (600161) Key Developments

Beijing Tiantan Biological Products Co., Ltd. Announces Earnings Results for the Full Year of Fiscal 2014

Beijing Tiantan Biological Products Co., Ltd. announced earnings results for the full year of fiscal 2014. For the year, the company announced basic earnings per share of CNY 0.25 and weighted average return on net assets of 6.84%.

Beijing Tiantan Biological Products Co., Ltd., Board Meeting, Mar 20, 2015

Beijing Tiantan Biological Products Co., Ltd., Board Meeting, Mar 20, 2015. Agenda: To discuss and approve the text of annual report of 2014 and its abstract; to consider the scheme of profit distribution in 2014; and to consider the proposal of daily connected transactions of 2014 and prediction on daily connected transactions in 2015.

Beijing Tiantan Biological Products Co., Ltd., Board Meeting, Jan 13, 2015

Beijing Tiantan Biological Products Co., Ltd., Board Meeting, Jan 13, 2015. Agenda: To appoint Deputy General Manager.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
600161:CH CNY40.98 CNY +3.02

600161 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Hualan Biological Engineering Inc CNY47.24 CNY +3.84
Jiangxi Boya Bio-Pharmaceutical Co Ltd CNY68.60 CNY +5.80
Shanghai RAAS Blood Products Co Ltd CNY60.64 CNY +1.43
View Industry Companies
 

Industry Analysis

600161

Industry Average

Valuation 600161 Industry Range
Price/Earnings 100.0x
Price/Sales 10.7x
Price/Book 10.1x
Price/Cash Flow 152.6x
TEV/Sales 8.6x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING TIANTAN BIOLOGICAL-A, please visit www.tiantanbio.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.